<DOC>
	<DOC>NCT00235287</DOC>
	<brief_summary>The purpose of this study is to determine whether a combination therapy with angiotensin-converting enzyme (ACE)-inhibitors and angiotensin receptor blockers reduces the arterial stiffness assessed by applantiontonometry more than a single treatment in kidney patients.</brief_summary>
	<brief_title>Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Creatinine: 150350 micromol/L Blood pressure &gt; 110 systolic Negative pregnancy test for fertile women Written and oral informed consent from the patient Treatment with both ACEinhibitors (ACEI) and angiotensin receptor blockers Pregnancy or breastfeeding Treatment with immunosuppressive medication, steroids or nonsteroidal antiinflammatory drugs (NSAIDs) Serious chronic heart failure (New York Heart Association [NYHA] IIIIV) Chronic liver disease Suspicion or verified kidney artery stenosis Cardiac arrhythmia and/or implanted pacemaker Myocardial infarction or cerebrovascular incidence within the last 3 months Allergy towards ACEI or angiotensin receptor blockers Amputation of a whole extremity or the crural or femoral part of the leg Dementia or a psychological condition that makes understanding of the examination conditions impossible Dialysis or renal transplantation Treatment with aldosterone antagonists Hyperkalemia &gt; 5.5 mmol/l Another serious chronic nonrenal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Angiotensin-Converting Enzyme Inhibitors</keyword>
	<keyword>type 1 angiotensin receptor antagonists</keyword>
	<keyword>blood pressure</keyword>
</DOC>